"Dehydroepiandrosterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
- 5 Androsten 3 beta hydroxy 17 one
Below are MeSH descriptors whose meaning is more general than "Dehydroepiandrosterone".
Below are MeSH descriptors whose meaning is more specific than "Dehydroepiandrosterone".
This graph shows the total number of publications written about "Dehydroepiandrosterone" by people in this website by year, and whether "Dehydroepiandrosterone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Dehydroepiandrosterone" by people in Profiles.
Franasiak J, Forman E, Scott R. DHEA supplementation can result in assay changes which may impact clinical decisions in IVF. J Assist Reprod Genet. 2017 07; 34(7):959.
Franasiak JM, Thomas S, Ng S, Fano M, Ruiz A, Scott RT, Forman EJ. Dehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA-S serum levels and progesterone assay interference that may impact clinical management in IVF. J Assist Reprod Genet. 2016 03; 33(3):387-391.
Forman EJ, Franasiak JM, Scott RT. Elevated progesterone levels in women on DHEA supplementation likely represent assay interference. J Assist Reprod Genet. 2015 Apr; 32(4):661.
Danley J, Kwait R, Peterson DD, Sendecki J, Vaughn B, Nakisbendi K, Sawicki J, Lande L. Normal estrogen, but low dehydroepiandrosterone levels, in women with pulmonary Mycobacterium avium complex. A preliminary study. Ann Am Thorac Soc. 2014 Jul; 11(6):908-14.
Mousa SA, Gallati C, Simone T, Dier E, Yalcin M, Dyskin E, Thangirala S, Hanko C, Rebbaa A. Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions. Aging (Albany NY). 2009 Mar 31; 1(4):412-24.
Miller KK, Cai J, Ripp SL, Pierce WM, Rushmore TH, Prough RA. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Drug Metab Dispos. 2004 Mar; 32(3):305-13.